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Mapping the mammalian ribosome quality 
control complex interactome using proximity 
labeling approaches
ABSTRACT Previous genetic and biochemical studies from Saccharomyces cerevisiae have 
identified a critical ribosome-associated quality control complex (RQC) that facilitates resolu-
tion of stalled ribosomal complexes. While components of the mammalian RQC have been 
examined in vitro, a systematic characterization of RQC protein interactions in mammalian 
cells has yet to be described. Here we utilize both proximity-labeling proteomic approaches, 
BioID and APEX, and traditional affinity-based strategies to both identify interacting proteins 
of mammalian RQC members and putative substrates for the RQC resident E3 ligase, Ltn1. 
Surprisingly, validation studies revealed that a subset of substrates are ubiquitylated by Ltn1 
in a regulatory manner that does not result in subsequent substrate degradation. We demon-
strate that Ltn1 catalyzes the regulatory ubiquitylation of ribosomal protein S6 kinase 1 and 
2 (RPS6KA1, RPS6KA3). Further, loss of Ltn1 function results in hyperactivation of RSK1/2 
signaling without impacting RSK1/2 protein turnover. These results suggest that Ltn1-medi-
ated RSK1/2 ubiquitylation is inhibitory and establishes a new role for Ltn1 in regulating mi-
togen-activated kinase signaling via regulatory RSK1/2 ubiquitylation. Taken together, our 
results suggest that mammalian RQC interactions are difficult to observe and may be more 
transient than the homologous complex in S. cerevisiae and that Ltn1 has RQC-independent 
functions.
INTRODUCTION
The successful decoding of mRNA into protein is not an error-free 
process. Errors during transcription, posttranscriptional mRNA pro-
cessing, or translation can result in the production of defective 
nascent chains that require ubiquitin-mediated degradation 
(Drummond and Wilke, 2009; Lykke-Andersen and Bennett, 2014; 
Harper and Bennett, 2016). Ribosome-associated quality control 
mechanisms facilitate the triage and subsequent proteasome-de-
pendent degradation of these potentially toxic defective translation 
products (Matsuda et al., 2014; Brandman and Hegde, 2016; 
Joazeiro, 2017). One such mechanism involves the cotranslational 
recruitment of a ribosome quality control (RQC) complex to termi-
nally stalled ribosomes (Brandman and Hegde, 2016; Joazeiro, 
2017). Elegant biochemical and genetic characterization of the RQC 
has resulted in the following model. First, terminally stalled ribo-
somes are sensed by unknown mechanisms that result in the initial 
regulatory ubiquitylation of 40S ribosomal proteins in a ZNF598-
dependent (Hel2 in Saccharomyces cerevisiae) manner (Garzia 
et al., 2017; Juszkiewicz and Hegde, 2017; Matsuo et al., 2017; 
Sundaramoorthy et al., 2017). The alternative ribosome rescue fac-
tors, Hbs1L and Pelota (Hbs1 and Dom34 in S. cerevisiae), in concert 
with ABCE1 facilitate splitting of the 40S and 60S subunits allowing 
for mRNA destruction (Shoemaker et al., 2010; Shoemaker and 
Green, 2012; Pisareva et al., 2011; Tsuboi et al., 2012). Previous 
studies have further identified RQC interacting proteins that can 
facilitate ribosome rescue and ribosome-quality control events 
(Ishimura et al., 2014; Matsuo et al., 2017). The ubiquitin ligase Ltn1, 
also known as Listerin, along with its cofactor nuclear export media-
tor factor (NEMF) (Rqc2/Tae2 in S. cerevisiae) ubiquitylates nascent 
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chains trapped with the released 60S ribosomal subunit, which al-
lows for subsequent p97/valosin-containing protein (VCP)-depen-
dent (Cdc48 in S. cerevisiae) extraction and subsequent protea-
somal degradation (Bengtson and Joazeiro, 2010; Brandman et al., 
2012; Defenouillere et al., 2013; Shao et al., 2013; Shao and Hegde, 
2014; Verma et al., 2013; Doamekpor et al., 2016; Shcherbik et al., 
2016; Kostova et al., 2017). Ltn1 has also been demonstrated to 
play a similar ribosome-associated quality control role with ribo-
somes docked at the ER or mitochondrial membranes during mito-
chondria and ER-localized protein transport (Crowder et al., 2015; 
von der Malsburg et al., 2015; Arakawa et al., 2016; Izawa et al., 
2017). Interestingly, degron mapping in S. cerevisiae suggests that 
Ltn1 can target degron-containing proteins for destruction in a man-
ner that is distinct from its well-characterized role in mediating RQC 
(Maurer et al., 2016). Despite the rapidly expanding molecular 
knowledge of Ltn1 function in S. cerevisiae, a systematic character-
ization of the mammalian RQC or Ltn1 has yet to be described.
Mice lacking listerin with an intact RING domain die during em-
bryonic development (Chu et al., 2009). However, forward genetic 
approaches in mice revealed a hypomorphic mutation in the listerin 
gene that resulted in a neurodegenerative phenotype in which the 
mice display motor defects later in life due to motor neuron death 
(Chu et al., 2009). Based on the well-characterized role for Ltn1 dur-
ing ribosome-associated quality control, it is hypothesized that de-
fective Ltn1 function in animals results in neurodegeneration 
through the accumulation of toxic defective translation products. In 
support of this hypothesis, mutations in mice that weaken transla-
tion fidelity or quality control mechanisms also result in neurode-
generation (Lee et al., 2006; Ishimura et al., 2014). Combined, these 
results suggest that elevating the levels of defective translation 
products beyond the capacity of quality control systems in neurons 
contributes to aging-associated degeneration. However, due to the 
lack of characterized endogenous Ltn1 substrates, it remains possi-
ble that other, uncharacterized RQC-independent Ltn1 functions 
contribute to the observed neurodegenerative phenotypes.
Here we utilize proximity-labeling proteomic approaches along 
with standard affinity-purification approaches to systematically char-
acterize the core mammalian RQC complex. Surprisingly, interac-
tions among the core RQC proteins Ltn1, p97/VCP, NEMF, and 
TCF25 were difficult to capture, even with proximity-labeling ap-
proaches. However, proximity-labeling identifies uncharacterized 
Ltn1 interacting proteins and we demonstrate that subsets of these 
are Ltn1 substrates. We show that Ltn1 can ubiquitylate members of 
the mammalian ribosomal S6 kinase family, RPS6KA1 and RPS6KA3 
(also known as RSK1 and RSK2) in a regulatory and nondegradative 
manner. Loss of Ltn1 function results in elevated RSK1 activity, indi-
cating that Ltn1 functions to restrict RSK1 activity. Taken together, we 
identify putative mammalian Ltn1 substrates and demonstrate that 
Ltn1 regulates mitogen-activated protein kinase (MAPK) signaling.
RESULTS
Utilization of proximity-labeling and traditional 
affinity-capture approaches to interrogate p97/VCP 
interacting proteins
Proximity-labeling approaches have been successfully utilized to 
characterize both interacting proteins for individual baits of interest 
and organelle proteomes (Kim and Roux, 2016). The BioID approach 
fuses a mutant version of the Escherichia coli biotin ligase, which 
prematurely releases activated biotinoyl-adenosine monophos-
phate (AMP), resulting in the biotinylation of neighboring interacting 
proteins (Roux et al., 2012). The APEX approach adds an ascorbate 
peroxidase to proteins of interest that, on addition of biotin-phenol 
and hydrogen peroxide, allow for the rapid and temporal biotinyl-
ation of neighboring proteins via a biotin-phenoxyl radical interme-
diate and has been successfully utilized to characterize a variety of 
interactomes (Rhee et al., 2013; Chen et al., 2015; Lam et al., 2015; 
Hung et al., 2016, 2017; Loh et al., 2016; Reinke et al., 2017a,b; 
Bersuker et al., 2018; Markmiller et al., 2018). While the BioID ap-
proach has been used to identify substrates for the well-character-
ized βTRCP1/2 cullin-RING ubiquitin ligase complex (Coyaud et al., 
2015), the APEX-approach has not been previously used to capture 
ligase substrates. To systematically characterize the mammalian 
RQC complex, we first utilized both the BioID and APEX proximity-
labeling approaches as well as standard affinity capture techniques 
to evaluate interacting partners for the well-characterized RQC fac-
tor p97/VCP. We first generated HEK293 cells with dox-inducible 
expression of FLAG-hemagglutinin (HA), FLAG-APEX2, or BirA-
R118G (denoted as BirA* hereafter)-FLAG–tagged p97/VCP using 
the Flp-In system to achieve stable single site integration of our 
transgenes. Cell lines expressing similarly tagged green fluorescent 
protein (GFP) were generated to serve as specificity controls. Tagged 
protein expression was induced for 16 h, and for BirA*-FLAG–
tagged GFP or p97/VCP-expressing cell lines, 50 μM biotin was 
added to the media. Protein biotinylation was induced in cell lines 
expressing FLAG-APEX2–tagged GFP or p97/VCP by adding biotin-
phenol to the cells for 1 h prior to a 1-min addition of hydrogen 
peroxide. Subsequent analysis of whole-cell lysates by SDS–PAGE 
verified protein biotinylation in BirA* and APEX2-tagged samples 
but not in FLAG-HA–tagged samples (Figure 1A).
We employed a SILAC (stable isotope labeling with amino acids 
in cell culture) approach to identify specific p97/VCP interacting 
proteins. To accomplish this, we metabolically labeled control 
GFP-expressing cell lines with heavy13C15N-arginine and lysine. 
After induction of protein expression and proximity-labeling, an 
equal number of light-labeled p97/VCP-expressing cells were 
mixed with heavy-labeled GFP-expressing cells. Cells were lysed, 
and for BirA* and APEX2-tagged samples, biotinylated proteins 
were isolated by streptavidin agarose under native lysis and IP 
conditions. For FLAG-HA–tagged samples, interacting proteins 
were isolated by native anti-FLAG immunoprecipitation. Analysis 
of isolated proteins by mass spectrometry allowed for the identifi-
cation of specific p97/VCP interacting proteins by examining the 
heavy:light (H:L) ratio of all identified and quantified proteins 
(Figure 1B and Supplemental Table S1). Proteins with a Log2 
transformed (H:L) ratio below –1 in replicate samples were de-
noted as putative p97/VCP interacting proteins. All three ap-
proaches identified known p97/VCP interacting proteins (Figure 
1, B and C, and Supplemental Figure S1A). However, the BioID 
approach routinely resulted in the identification of more known 
p97/VCP interactors including those recently shown to interact 
with p97/VCP with relatively weaker affinities (Figure 1C and Sup-
plemental Figure S1, A and B) (Xue et al., 2016). Each approach 
resulted in the identification of unique p97/VCP interacting pro-
teins with surprisingly little overlap among the three approaches 
(Figure 1D). These results suggest, in agreement with previous 
studies (Coyaud et al., 2015), that combining approaches results 
in the identification of both more known and putative interacting 
proteins for a given bait compared with any individual technique.
BioID identifies both known and uncharacterized Ltn1 
interacting proteins
Ltn1 has a well-established role in ribosome-associated quality con-
trol, and the S. cerevisiae RQC complex has been previously bio-
chemically characterized (Brandman et al., 2012). To both verify the 
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presence of an orthologous mammalian RQC complex and to identify 
new Ltn1 interacting proteins, we generated stable cell lines with in-
ducible expression of FLAG-HA-, BirA*-FLAG-, or FLAG-APEX2–
tagged Ltn1 in a manner identical to our p97/VCP-expressing cell 
lines. On the basis of the results obtained using p97/VCP, we utilized 
all three interaction mapping approaches to identify the greatest 
number of potential Ltn1 interacting proteins. We again used GFP-
expressing cell lines as a specificity control but switched to a label-
free proteomic approach to facilitate a simpler cell culture scheme. 
Ltn1 protein expression was significantly lower than GFP in all three 
cell lines, which resulted in reduced protein biotinylation for BirA*-
FLAG- and FLAG-APEX2–tagged Ltn1-expressing lines compared 
with control GFP-expressing cell lines (Figure 2A). FLAG immunopre-
cipitations from cell lysates with FLAG-HA–tagged Ltn1 or GFP or 
streptavidin pull downs from lysates with BirA*-FLAG- or FLAG-
APEX2–tagged Ltn1 or GFP were done in triplicate. Isolated proteins 
were identified by mass spectrometry, and 
high-confidence interacting proteins were 
annotated using a modified version of the 
CompPASS scoring matrix (Supplemental 
Table S2) (Sowa et al., 2009). The known Ltn1 
interacting protein NEMF was only identified 
from cells expressing BirA*-FLAG–tagged 
Ltn1 compared with p97/VCP, which was 
identified in all conditions in both GFP- and 
Ltn1-expressing cells (Figure 2B). Standard 
affinity-purification approaches identified the 
greatest number of putative Ltn1 interacting 
proteins (Figure 2C). Scoring of all putative 
Ltn1 interacting proteins identified using the 
BioID approach revealed NEMF to be the 
top-scoring protein (Figure 2D and Supple-
mental Table S2). Other top-scoring Ltn1 in-
teracting proteins included four proteins im-
plicated in tubulin glutamylation (LRRC49, 
NICN1, TPGS1, and TPGS2), two tRNA mod-
ification enzymes (TRMT2A and TYW3), and 
a p90 ribosomal S6 kinase (RPS6KA1) (Figure 
2D). Interestingly, other putative mammalian 
RQC proteins, TCF25 and p97/VCP, as well 
as 60S ribosomal proteins were not identified 
as specific Ltn1 interacting proteins.
Previous studies have demonstrated that 
the RQC complex composed of Ltn1, Rqc2/
Tae2, Rqc1, and Cdc48 can be isolated from 
S. cerevisiae extracts using epitope-tagged 
Rqc1 (Brandman et al., 2012). Further, stud-
ies in mammalian cells demonstrated that 
Ltn1 shifted from a ribosome-free fraction 
to a 60S containing sucrose-density fraction 
on cycloheximide treatment to cells prior to 
fractionation (Shao et al., 2013). Taken to-
gether, it is possible that we were unable to 
detect the mammalian RQC due to our use 
of tagged Ltn1 isolated from untreated 
cells. To systematically examine the network 
of RQC interactions in mammalian cells, we 
generated cell lines with dox-inducible ex-
pression of FLAG-HA–tagged TCF25 (puta-
tive Rqc1 homologue) and NEMF (Rqc2/
Tae2 in S. cerevisiae). We also generated 
cell lines expressing Ltn1 lacking its C-ter-
minal RING domain (ΔRING) to examine whether expression of a 
catalytically inactive version of Ltn1 resulted in capture of known 
RQC components or putative substrates. These new cell lines were 
generated using the same Flp-In approach utilized for the other 
tested RQC components. We used sucrose-density gradient frac-
tionation to determine if putative RQC components were present in 
ribosome containing fractions in extracts from untreated and cyclo-
heximide (CHX)-treated cells. Both exogenous and endogenous 
Ltn1, as well as exogenous TCF25 and NEMF, were primarily pres-
ent in fractions that were devoid of 60S and 80S ribosomes in 
untreated FLAG-HA-Ltn1–, FLAG-HA-TCF25–, or FLAG-HA-NEMF–
expressing cells (Figure 3A). Cycloheximide treatment resulted in 
variable shifting of endogenous Ltn1 into ribosome-containing frac-
tions, whereas the distribution of exogenous Ltn1, TC25, and NEMF 
was largely unchanged on CHX treatment with most of the protein 
present in ribosome-free fractions (Figure 3A). Previous studies 
FIGURE 1: Utilization of three proteomic methods toward the identification of p97/VCP 
interacting proteins. (A) 293 Flp-In cells with dox-induced expression of FLAG-HA(F), BirA*-
FLAG(B), or FLAG-APEX2(A)–tagged GFP or VCP were treated with doxycycline overnight. For 
BirA*-FLAG-GFP or VCP-expressing cells, 50 μM biotin was addd to the growth media for 
16–20 h prior to cell harvesting. For FLAG-APEX2-GFP of VCP-expressing cells protein 
biotinylation was induced by addition of 500 μM biotin-phenol for 1 h followed by a 1-min 
treatment of 1.5 mM hydrogen peroxide. Whole-cell extracts were immunoblotted with α-FLAG 
antibodies or probed with streptavidin-conjugated horseradish peroxidase (SA-HRP). 
(B) Heavy-labeled GFP-expressing control cells were mixed with light-labeled VCP-expressing 
cells that were similarly tagged as indicated. Depicted is the scatter plot of log2 heavy to light 
(H:L) ratios of streptavidin or anti-FLAG–isolated and identified proteins from replicate 
experiments for APEX2 (top), BirA* (middle), or FLAG-HA–tagged VCP (bottom). The bait VCP 
protein is indicated in red, and known VCP interacting proteins are depicted in blue. For panels 
B–D, FLAG-HA and BirA* enrichments were performed in triplicate, and APEX-based 
experiments were performed in duplicate. (C) Log2 heavy to light (H:L) ratios for known VCP 
interacting proteins identified from FLAG-APEX2 (red)-, BirA*-FLAG (blue)-, or FLAG-HA 
(green)-expressing cell extracts is shown. Error bars represent SD of the ratios from triplicate 
(FLAG-HA, and BirA*-FLAG experiments) or duplicate (FLAG-APEX2) experiments. (D) Venn 
diagram depicting the overlap of identified VCP interacting proteins for each of the three 
proteomic platforms.
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have demonstrated that the 40S protein Rps3 becomes monoubiq-
uitylated on CHX-induced translation elongation inhibition (Higgins 
et al., 2015). We observe this Rps3 ubiquitylation event that con-
firms successful translation elongation inhibition in CHX-treated 
cells. We then determined the interaction landscape of each RQC 
protein with and without CHX treatment using FLAG immunopre-
cipitations from native whole-cell extracts (Figure 3, B and C, and 
Supplemental Table S3). Compared to control cells expressing GFP, 
we detected a CHX-inducible interaction between Ltn1 and NEMF 
using either Ltn1 or NEMF as the bait protein (Figure 3D). An inter-
action between TCF25 and NEMF was also observed but in a CHX-
independent manner, and no specific interaction with p97/VCP, 40S 
ribosomal proteins, 60S ribosomal proteins, or other translation 
initiation factors was observed with any RQC protein (Figure 3, D 
and E, and Supplemental Table S3). Together, these results indicate 
that the interaction with Ltn1 and NEMF can be stimulated by trans-
lation elongation inhibition. Further, the majority of Ltn1 in 293T 
cells is not found in ribosome-containing 
fractions, which suggests mammalian Ltn1 
may have ribosome-independent functions. 
While it is possible that the mammalian 
RQC complex is less biochemically stable 
compared with its counterpart in S. cerevi-
siae, we cannot rule out the possibility that 
overexpression of one or multiple RQC fac-
tors may result in altered complex stoichi-
ometry and possible RQC destabilization.
Ltn1 ubiquitylates TYW3 and RSK1/2 
in a regulatory manner
We first sought to validate the Ltn1 interact-
ing proteins identified by the BioID ap-
proach. To accomplish this, we generated 
cell lines expressing dox-inducible BirA*-
FLAG–tagged LRRC49, NICN1, TTLL1, 
RSK2 (RPS6KA3), or TYW3 (Figure 4A) using 
293 Flp-In cells. We also generated a cell line 
expressing BirA*-FLAG–tagged Ltn1 that 
lacks its RING domain to determine whether 
any of the observed Ltn1 interactions were 
ubiquitin ligase activity dependent. Repli-
cate BioID analysis of wild type and ΔRING 
Ltn1 confirmed the originally identified Ltn1 
interactions and demonstrated these inter-
actions to be independent of the RING do-
main within Ltn1 (Figure 4B). BioID analysis 
of putative Ltn1 interacting proteins demon-
strated that RSK2 and TYW3 interacted with 
Ltn1 in a reciprocal manner (Figure 4C and 
Supplemental Table S4). Despite validating 
the interaction between members of the tu-
bulin glutamylation complex (Figure 4D), we 
were unable to detect an interaction be-
tween Ltn1 and any of the glutamylation fac-
tors (LRRC49, NICN1, or TTLL1) at a level 
greater than that observed in BirA*-GFP-ex-
pressing cells (Figure 4, B and D). These re-
sults suggest that the association between 
Ltn1 and glutamylation factors may be driven 
by the overexpression of Ltn1 or may be oth-
erwise enhanced by the localization and 
abundance of BirA*-FLAG–tagged Ltn1. De-
spite the inability to validate the interaction with Ltn1 and the tubulin 
glutamylation factors, we were able to validate the interaction be-
tween Ltn1 and p90 ribosomal S6 kinases as well as with TYW3.
To determine whether Ltn1 can ubiquitylate the identified inter-
acting proteins, we transiently transfected myc-tagged versions of 
putative Ltn1 substrates along with HA-tagged ubiquitin in HEK293 
cells with stable and dox-inducible expression of either wild type or 
ΔRING Ltn1. Ubiquitylating proteins were isolated under native con-
ditions by HA immunoprecipitation, and the presence of putative 
Ltn1 substrates was probed using myc immunoblots. High-molecular-
weight forms, which are presumably ubiquitylated RSK1, RSK2, and 
TYW3, could be observed within whole-cell extracts as well as HA 
immunoprecipitates (Figure 5A). The ubiquitylation of myc-tagged 
RSK1, RSK2, and TYW3 observed in whole-cell extracts were depen-
dent on expression of wild-type Ltn1 as expression of ΔRING Ltn1 did 
not support ubiquitylation of exogenously expressed RSK1, RSK2, or 
TYW3 (Figure 5A). In comparison, ubiquitylation of myc-tagged 
FIGURE 2: Identification of Ltn1-interacting proteins using proximity labeling approaches. 
(A) 293 Flp-In cells with dox-induced expression of FLAG-HA(F)-, BirA*-FLAG(B)-, or FLAG-
APEX2(A)–tagged GFP or Ltn1 were treated with doxycycline overnight, and protein 
biotinylation was induced as described for BirA*- or APEX2-tagged cell lines. Whole-cell extracts 
were immunoblotted with a-FLAG antibodies or probed with SA-HRP. Short (s) or long (l) 
exposures are depicted. (B) The summed total spectral counts (TSCs) from replicate experiments 
corresponding to NEMF (left) or VCP (right) from streptavidin or anti-FLAG–isolated and 
identified proteins from FLAG-HA(F)-, BirA*-FLAG(B)-, or FLAG-APEX2(A)–tagged GFP- or 
Ltn1-expressing cell extracts. For panels B–D, all IPs were performed in triplicate from distinct 
experiments and cell lysates. (C) The number of high-confidence interacting proteins (HCIPs) for 
Ltn1 for each of the three proteomic platforms was determined using a modified CompPASS 
scoring method. (D) The normalized interaction scores as determined by the CompPASS scoring 
method for top-scoring Ltn1 interacting proteins identified using the BioID approach is shown.
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TTLL1 was only minorly altered by ΔRING Ltn1 expression, and 
NICN1 ubiquitylation was completely unchanged by ΔRING Ltn1 ex-
pression. The presence of the monomeric and unmodified myc-
tagged proteins in HA immunoprecipitates suggests that a portion of 
these proteins may interact with ubiquitin in noncovalent manner and 
possibly as part of a larger complex. However, the presence of high-
molecular-weight modified forms of RSK1, RSK2, and TYW3 in whole-
cell extracts and HA immunoprecipitates that are observed only on 
expression of wild type and not inactive Ltn1 suggests that Ltn1 can 
ubiquitylate these proteins within cells.
Ltn1 ubiquitylation of RSK1, RSK2, and TWY3 could either result 
in degradation or impart a regulatory function on target proteins 
FIGURE 3: Systematic proteomic interrogation of the mammalian RQC complex. (A) 293 Flp-In cells with dox-induced 
expression of FLAG-HA (FH)–tagged Ltn1 or TCF25, or 293T cells with constitutive stable-expression of FLAG-HA–
tagged NEMF, were either untreated (top) or treated with 100 μg/ml cycloheximide (CHX, bottom) for 1 h. Native cell 
extracts were separated on a 5–45% linear sucrose gradient. Inputs (In) and isolated fractions across the gradient were 
immunoblotted as indicated. Note the appearance of the slower migrating ubiquitylated RPS3 in CHX-treated samples 
as a marker for CHX treatment. (B) 293 Flp-In cells with dox-induced expression of the indicated FH-tagged proteins 
were either untreated (top) or treated with 100 μg/ml cycloheximide (CHX, bottom) for 1 h. Whole-cell extracts were 
immunoblotted as indicated. (C) Total spectral counts (TSCs) to the corresponding bait proteins from anti-HA–isolated 
proteins from cell lines expressing the indicated FH-tagged proteins is depicted. (D) Total spectral counts (TSCs) 
corresponding to identified Ltn1, NEMF, TCF25, or VCP from anti-HA–isolated proteins from the indicated FH-tagged 
protein expressing cell extracts. Cells were either untreated or treated with CHX as indicated. (E) Total spectral counts 
(TSCs) corresponding to the indicated representative proteins for 40S, 60S, and translation initiation factors identified 
from either untreated or CHX-treated cells from FH-tagged GFP (black)-, wild type Ltn1 (red)-, ΔRING Ltn1 (green)-, 
NEMF (blue)-, or TCF25 (orange)-expressing cells. For panels C–E, summed TSCs are shown from triplicate runs of 
individual experiments.
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distinct from degradation. To differentiate between these two 
possibilities, we determined if the steady-state abundance of puta-
tive Ltn1 substrates was altered on loss of Ltn1 function as would be 
expected for degradation-based ubiquitylation. The steady-state 
protein levels of either exogenous or endogenous RSK1, RSK2, and 
TTLL1 were unchanged on small interfering RNA (siRNA)-mediated 
knockdown of Ltn1 (Figure 5, B and C). Further, exogenous TYW3 
steady-state protein levels were similarly unaltered on Ltn1 knock-
down (Figure 5B). We then directly examined protein turnover dy-
namics using cycloheximide time-course experiments to confirm that 
loss of Ltn1 did not result in delayed protein turnover of putative 
substrates. Knockdown of Ltn1 using multiple siRNAs in our HEK293 
cell lines with dox-inducible expression of RSK2, TTLL1, or TYW3 did 
not result in delayed degradation kinetics of any of the tested sub-
strates (Figure 5D). There appeared to be a slight acceleration of 
FLAG-HA–tagged TTLL1 protein degradation on Ltn1 knockdown 
(Figure 5D). We also did not observe any alteration in the protein 
degradation kinetics of endogenous RSK1 in either 293T or HCT116 
cells on Ltn1 knockdown (Figure 5E). Taken together, our results indi-
cate that Ltn1 can ubiquitylate RSK1, RSK2, and TYW3, and this ubiq-
uitylation does not function to target these proteins for degradation.
Ltn1 regulates RSK1/2 activity on mitogen-activated cell 
signaling
Because knockdown of Ltn1 did not alter RSK1 or RSK2 protein turn-
over, we examined if RSK1/2 activity was altered on loss of Ltn1 
function. First, we established an RSK1/2 activity assay. A bevy of 
substrates for RSK1/2 have been previously 
described (Sapkota et al., 2007; Romeo 
et al., 2012). Many RSK1/2 substrates are 
not exclusive to RSK1/2 and can be phos-
phorylated by other kinases, which can 
complicate an analysis of RSK1/2 activity us-
ing these substrates. For instance, RSK1/2 
can phosphorylate RPS6 on serine 235 and 
236 but these same sites are also phosphor-
ylated by p70 S6 kinase. In searching for ex-
clusive RSK1/2 targets, a previous study 
demonstrated that RSK1/2 can phosphory-
late TSC2 at serine 1798 and that this site 
was distinct from other mTOR-dependent 
TSC2 phosphorylation events (Roux et al., 
2004). To independently evaluate this TSC2 
phosphorylation event, we treated 293T 
cells with increasing concentrations of the 
mTOR inhibitors rapamycin and Torin-1, as 
well as a potent AKT1 inhibitor (MK2206). 
The levels of phosphorylated RPS6 (S6) and 
p70 S6 kinase (S6K) were reduced on ra-
pamycin, Torin-1, and MK2206 (AKT inhibi-
tor), demonstrating the efficacy of these in-
hibitors as well as establishing that RPS6 
phosphorylation could not be used to di-
rectly examine RSK1/2 activity. Further, To-
rin-1 and AKT inhibition resulted in a reduc-
tion of ERK1/2 phosphorylation, indicating 
that these inhibitors widely impact mitogen-
activated protein kinase (MAPK) signaling in 
otherwise unperturbed cells. However, ra-
pamycin, Torin-1, or MK2206 treatment did 
not reduce S1798 TSC2 phosphorylation in 
unperturbed cells, indicating that this phos-
phorylation event was not impacted by mTOR or AKT1 signaling 
(Figure 6A). We then tested the impact of these same mTOR and 
AKT1 inhibitors on overt activation of MAPK signaling in serum-
starved cells by the addition of phorbol ester (phorbol 12-myristate 
13-acetate [PMA]). PMA treatment in serum-starved cells resulted in 
robust phosphorylation of ERK1/2 as well as increased phosphoryla-
tion of TSC2 (S1798) in a manner that was unaltered by mTOR or 
AKT1 inhibition (Figure 6B). RSK1 phosphorylation itself was also 
stimulated by PMA treatment but this phosphorylation was unaf-
fected by mTOR or AKT1 inhibition (Figure 6B). Phosphorylation of 
S6K and 4EBP was substantially reduced by Torin-1 treatment as 
expected, but RPS6 phosphorylation itself, while reduced on mTOR 
or AKT1 inhibition, was not completely abolished in serum-starved 
and PMA-activated cells (Figure 6B). Addition of the RSK1 inhibitor 
BI-D1870 to serum-starved and PMA-activated cells completely 
blocked TSC2 S1798 phosphorylation without impacting upstream 
ERK1/2 or RSK1 phosphorylation or the mTOR-dependent S6K 
phosphorylation (Figure 6C) (Sapkota et al., 2007). Interestingly, 
RPS6 phosphorylation was reduced by either Torin-1 or BI-D1870, 
indicating that multiple kinases can generate this phosphorylation 
event (Figure 6C). Consistent with previous results, our data indicate 
that TSC2 phosphorylation at S1798 can be used as a specific 
RSK1/2 activity assay.
To determine whether Ltn1 regulates RSK1/2 activity, we knocked 
down Ltn1 expression and examined MAPK signaling in serum-
starved cells activated with PMA. Loss of Ltn1 expression resulted in 
increased TSC2 phosphorylation compared with controls without 
FIGURE 4: Validation of candidate Ltn1 interacting proteins. (A) 293 Flp-In cells with dox-
induced expression of the indicated BirA*-FLAG–tagged proteins were generated. Total spectral 
counts (TSCs) corresponding to BirA (bait) from streptavidin-isolated proteins from each of the 
eight dox-inducible cell lines. (B) Total spectral counts (TSCs) corresponding to the indicated 
proteins isolated from streptavidin pull downs from BirA*-tagged GFP (green)-, wild-type Ltn1 
(blue)-, or ΔRING Ltn1 (red)-expressing cells. The identified protein in indicated on the x-axis. 
(C) Total spectral counts (TSCs) corresponding to Ltn1 from streptavidin-isolated proteins from 
the indicated BirA*-FLAG–tagged protein-expressing cell lines. The different pull downs for 
separate cell lines are indicated on the x-axis. (D) Total spectral counts (TSCs) corresponding to 
the indicated proteins isolated from streptavidin pull-downs from BirA*-tagged GFP (green)-, 
LRRC49 (blue)-, NICN1 (red)-, or TTLL1 (orange)-expressing cells. TSCs corresponding to the 
bait proteins were omitted to allow for easier visualization of interactions between complex 
members. The identified protein in indicated on the x-axis. For all panels, summed TSCs are 
shown from triplicate runs of individual experiments.
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FIGURE 5: Ltn1 ubiquitylates a subset of identified interacting proteins in a regulatory manner. (A) 293 Flp-In cells with 
dox-induced expression of FLAG-HA–tagged wild type or ΔRING Ltn1 were transfected with HA-ubiquitin and the 
indicated myc-tagged Ltn1 interacting protein. Whole-cell lysates or anti-HA immune-complexes isolated under native 
conditions were immunoblotted as indicated. (B) 293 Flp-In cells with dox-induced expression of the indicated FLAG-HA 
(FH)-tagged proteins were transfected with control scrambled siRNA oligos (siC) or three separate Ltn1-targeting siRNA 
oligos. Whole-cell extracts were immunoblotted as indicated. (C) 293T cells were transfected with control scrambled 
siRNA oligos (siC) or three separate Ltn1-targeting siRNA oligos. Whole-cell extracts were immunoblotted as indicated. 
(D) 293 Flp-In cells with dox-induced expression of FLAG-HA–tagged RSK2, TTLL1, or TYW3 were transfected with 
control scrambled siRNA oligos (siC) or Ltn1-targeting siRNA oligos. Seventy-two hours after siRNA transfection, cells 
were either untreated or treated with 100 μg/ml cycloheximide (CHX) for the indicated times. After treatment, cells 
were harvested and whole-cell extracts were immunoblotted as indicated. (E) 293T cells (left) or HCT116 cells (right) 
were transfected with control scrambled siRNA oligos (siC) or Ltn1-targeting siRNA oligos. Seventy-two hours after 
siRNA transfection, cells were either untreated or treated with 100 μg/ml cycloheximide (CHX) for the indicated times. 
After treatment, cells were harvested, and whole-cell extracts were immunoblotted as indicated.
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altering upstream MAPK signaling (Figure 7A). Consistent with our 
previous results, loss of Ltn1 did not alter the abundance of RSK1. 
We validated that loss of Ltn1 resulted in elevated RSK1/2 activity in 
replicate experiments, as well as confirmed that the observed PMA-
induced TSC2 phosphorylation was independent of mTOR activity 
but completely dependent on RSK1/2 activity (Figure 7, B and C). 
Summing together data from replicate experiments revealed a con-
sistent elevation of phosphorylated TSC2 relative to total TSC2 lev-
els on Ltn1 knockdown using three separate siRNA oligos (Figure 
7C). To determine whether the observed Ltn1-dependent regula-
tion of RSK1 signaling was associated with other RQC factors, we 
examined RSK1/2 activity on NEMF knockdown. The PMA-induced, 
RSK1/2-dependent TSC2 phosphorylation was largely unperturbed 
by loss of NEMF function, suggesting that Ltn1-mediated regulation 
of RSK1/2 activity was separable from its RQC function (Figure 7D). 
We confirmed the efficacy of the NEMF knock down by examining 
the levels of BirA*-FLAG-NEMF in 293 Flp-In cell lines after over-
night dox treatment (Figure 5E). Taken to-
gether, our results both demonstrate that the 
BioID approach successfully identified un-
characterized Ltn1 substrates and suggest 
that Ltn1-dependent, regulatory ubiquity-
lation of RSK1/2 normally restrains RSK1 ac-
tivity during MAPK signaling. Our results also 
demonstrate a possible ribosome-indepen-
dent role for Ltn1 in regulating the activity of 
diverse substrates.
DISCUSSION
Proximity-labeling approaches can 
identify transient interacting proteins 
for ubiquitin-pathway components
Standard affinity-capture approaches or other 
substrate-trapping methods coupled with 
mass spectrometry have been widely used to 
identify candidate substrates for ubiquitin li-
gases of interest (Iconomou and Saunders, 
2016; O’Connor and Huibregtse, 2017). Prox-
imity labeling techniques allow for the irre-
versible biotinylation of neighboring proteins 
that potentially offer the advantage of captur-
ing transient interacting proteins that do not 
stably associate with ubiquitin ligases and 
would be difficult to capture using standard 
affinity capture approaches (Hung et al., 
2016; Kim and Roux, 2016; Hesketh et al., 
2017). The utility of both BioID and APEX ap-
proaches have been robustly demonstrated 
to identify interactomes for diverse proteins in 
diverse organisms (Rhee et al., 2013; Chen 
et al., 2015; Lam et al., 2015; Hung et al., 
2016, 2017; Loh et al., 2016; Lobingier et al., 
2017; Reinke et al., 2017a,b). Here we utilized 
both BioID and APEX techniques in addition 
to standard affinity-capture approaches to-
ward the identification of interacting proteins 
for cytoplasmic localized ubiquitin pathway 
components. Each of the three proteomic 
platforms employed in this study identified 
known interacting partners for p97/VCP. How-
ever, BioID routinely resulted in the identifica-
tion of more known interactors for p97/VCP 
and Ltn1. Interestingly, there was little overlap in the interactomes 
identified by each technique, suggesting that the parallel use of all 
three techniques can be used to identify larger numbers of putative 
ligase substrates. While BioID seemingly outperformed APEX and 
affinity-capture methods, a caveat of the BioID approach is that it is 
limited to steady-state conditions and is therefore unsuitable for the 
study of dynamic changes in interactomes in response to cell stim-
uli. The continued development of biotin ligase variants that can be 
used in the BioID approach will likely improve this method to allow 
greater temporal control over labeling conditions. Currently, be-
cause of the short labeling time scales, APEX-based methods are 
better suited to study protein interaction dynamics (Lobingier et al., 
2017). Compared to other proteomic methods, APEX-based ap-
proaches did not identify the most known or novel interactors for 
the cytoplasmic proteins tested here. However, this result could very 
well be restricted to the proteins tested here as we and others have 
successfully utilized APEX for to map a diversity of interactomes. A 
FIGURE 6: Validation of RSK1/2-dependent TSC2 phosphorylation at serine 1798. (A) 293T 
cells were treated with increasing concentrations of rapamycin, Torin 1, or the AKT1 inhibitor 
MK2206 for 1 h. Whole-cell extracts were immunoblotted as indicated. (B) 293T cells were 
serum starved overnight and were then treated with rapamycin, Torin 1, or MK2206 as 
indicated for 1 h prior to PMA addition for 15 min. After the 15-min PMA treatment, cells were 
harvested on ice, and whole-cell extracts were immunoblotted as indicated. Filled black circles 
indicate the following drug concentrations: PMA, 1 μM; rapamycin, 100 nM; torin-1, 100 nM; 
MK2206, 1 μM. Black outlined gray circles indicate the following drug concentrations: PMA, 
1 μM; rapamycin, 250 nM; torin-1, 250 nM, MK2206, 5 μM. (C) 293T cells were serum starved 
overnight and were then treated with Torin-1 or RSK inhibitor (RSKi, BI-D1870) as indicated for 
1 h prior to PMA addition for 15 min. Whole-cell extracts were immunoblotted as indicated. 
Filled black circles indicate the following drug concentrations: PMA, 1 μM; torin-1, 100 nM; 
RSKi, 10 μM.
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FIGURE 7: Ltn1 activity regulates RSK1/2 signaling. (A) 293T cells were transfected with control siRNA oligos (siC) or 
three separate Ltn1-targeting siRNA oligos. Two days after transfection, cells were serum starved overnight and were 
then untreated or treated with 1 μM PMA for 15 min. Whole-cell extracts were immunoblotted as indicated. (B) 293T 
cells were transfected with control siRNA oligos (siC) or three separate Ltn1-targeting siRNA oligos. Two days after 
transfection, cells were serum starved overnight and were then treated with 100 nM Torin 1 or 10 μM RSK inhibitor 
(RSKi) as indicated for 1 h prior to PMA treatment for 15 min. Whole-cell extracts were immunoblotted as indicated. 
(C) The band intensities from immunoblots from replicate experiments in 293T cells where Ltn1 was knocked down with 
individual siRNA oligos and the levels of pTSC2 (S1798) and total TSC2 were measured on serum starvation and 
subsequent PMA addition were quantified using Image Lab software volume tools (Bio-RAD). All immunoblots were 
imaged using a ChemiDoc XRS+ system which uses a charged-coupled device (CCD) detection system. A ratio of the 
background corrected band intensities of pTSC2:TSC2 was generated for each siRNA oligo targeting Ltn1 and 
normalized to the ratio observed in siControl-treated cells. Error bars represent SD (N = 5 for siLtn1 oligo 1 and 3, N = 4 
for siLtn1 oligo 2). (D) 293T cells were transfected with control siRNA oligos (siC) or three separate oligos targeting Ltn1 
or NEMF. Two days after transfection, cells were serum starved overnight and were then untreated or treated with 1 μM 
PMA for 15 min. Whole-cell extracts were immunoblotted as indicated. (E) 293 Flp-In cells with dox-induced expression 
of BirA*-FLAG-NEMF were transfected with control scrambled siRNA oligos (siC) or NEMF-targeting siRNA oligos. 
Forty-eight hours after siRNA transfection, BirA*-FLAG-NEMF expression was induced with dox for 16 h before cells 
were harvested. Whole-cell extracts were immunoblotted as indicated.
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more complete and careful comparison of these methods with di-
versely localized bait proteins is needed to more fully evaluate the 
strengths and weaknesses of each approach.
Ribosome-independent roles for Ltn1
Ltn1 has a clear role in ribosome-associated quality control and has 
been repeatedly shown to mediate destruction of model defective 
nascent substrates within S. cerevisiae and human cells as well as in 
vitro (Brandman and Hegde 2016). Subsequent structural studies 
nicely define how the extended structure of Ltn1 results in binding 
to separated 60S ribosomal subunits allowing Ltn1, in concert with 
NEMF (Rqc2/Tae2), to both contact the exposed 40S interaction 
surface of the 60S particle and position the RING domain of Ltn1 
near the ribosome nascent chain exit tunnel (Lyumkis et al., 2014; 
Shao et al., 2015; Shen et al., 2015; Doamekpor et al., 2016). Fur-
ther, loss of Ltn1 function in S. cerevisiae results in Rqc2/Tae2-de-
pendent carboxy-terminal extension of nascent chains by addition 
of alanine and threonine residues (CATylation) and subsequent pro-
tein aggregation (Choe et al., 2016; Yonashiro et al., 2016). These 
results suggest that RQC functions to both drive Ltn1-dependent 
nascent chain destruction and to engage with chaperone systems 
when Ltn1 fails. However, most of the in vivo studies characterizing 
Ltn1 and RQC function have been done in S. cerevisiae, and CAT-
ylation has only been demonstrated in S. cerevisiae. Further, quanti-
tative proteomic studies in a range of human cell lines indicate that 
ribosomes are 100× more abundant than Ltn1, suggesting that Ltn1 
capacity during RQC events is limited in mammalian cells (Wisniewski 
et al., 2014; Harper and Bennett, 2016). Our results demonstrate 
that a substantial portion of mammalian Ltn1 is not ribosome associ-
ated at steady state or on complete inhibition of translation elonga-
tion. Further, proteomic characterization of mammalian Ltn1 inter-
acting proteins using either affinity capture or proximity-labeling 
techniques did not identify ribosomal proteins as specific Ltn1 inter-
actors. It is possible this interaction cannot be sampled due to limi-
tations in the approaches utilized here. However, our data suggest 
that, along with its well-characterized RQC role, Ltn1 may have ribo-
some-independent functions.
Protein homeostasis modification through Ltn1-mediated 
regulatory ubiquitylation
Mammalian Ltn1 (Listerin) was first characterized through a murine 
forward genetic screen to identify genes involved in neurodegen-
eration (Chu et al., 2009). This study identified hypomorphic muta-
tions in Listerin that resulted in progressive neuronal death and 
motor-neuron dysfunction (Chu et al., 2009). Subsequent elucida-
tion of the role Ltn1 plays in ribosome-associated quality control led 
to the speculation that the accumulation of defective nascent chains 
in the absence of Ltn1 function contributed to the neurodegenera-
tive phenotype observed in lister mice. However, the lack of charac-
terized endogenous Ltn1 substrates has prevented a careful exami-
nation of whether Ltn1’s RQC function or another undetermined 
Ltn1 function contributes to the observed neurological phenotype. 
Our results present a new role for Ltn1 outside of its known RQC 
function. Our results highlight an uncharacterized regulatory interac-
tion between Ltn1 and the p90 ribosomal S6 kinases RSK1 and 
RSK2. These cytosolic kinases regulate many cellular functions, in-
cluding cell cycle, proliferation, and mRNA translation (Romeo et al., 
2012; Lara et al., 2013). Our data suggest that regulatory, nondeg-
radative Ltn1-mediated ubiquitylation inhibits RSK1/2 activity. As 
such, loss of Ltn1 may result in unrestrained RSK1/2 activity during 
MAPK signaling and may drive translation during conditions that 
would otherwise restrain protein production. Ltn1-mediated regula-
tory ubiquitylation was also observed for TYW3, which operates 
within a conserved multienzyme cascade that catalyzes wybutosine 
modification of phenylalanine-decoding tRNAs (Noma et al., 2006; 
Perche-Letuvee et al., 2014). How Ltn1-mediated regulatory ubiqui-
tylation impacts TYW3 function is unknown, but this observation 
provides another example of how non-ribosome-associated Ltn1 
may regulate protein homeostasis in noncanonical ways.
MATERIALS AND METHODS
Chemicals and antibodies
The following inhibitors/chemicals and antibodies were used in this 
study.
Cycloheximide (Enzo Life Sciences, 380-269-G005), PMA (EMD 
Millipore; 524400), Torin 1 (Tocris Bioscience; 4247), rapamycin 
(EMD Millipore; 553212), RSKi/BI-D1870 (Selleck Chemicals; S2843), 
MK-2206 (Selleck Chemicals; S1078), doxycycline (Fisher Biore-
agents; BP26535), biotin phenol/biotinyl tyramide (Adipogen; CDX-
B0270), and biotin (Sigma; B4639).
Monoclonal anti-HA-agarose mouse (Sigma; A2095), streptavi-
din agarose resin (Pierce; 20347), anti-FLAG M2 mouse (Sigma; 
F3165), streptavidin horseradish peroxidase (HRP) (Cell Signaling 
Technologies [CST]; 3999), pERK1/2 (CST; 4370), pRSK1 (CST; 9341), 
RSK1 (CST; 8408), RSK1/2/3 (CST; 14813, pAKT1 (CST; 4060), pS6K 
(CST; 9234), pS6 (CST; 8585), p4EBP1 (CST; 2855), myc (CST: 2278), 
tubulin (CST; 3873), TSC2 (Santa Crux; sc271314), pTSC2 (Santa 
Cruz; sc293149), HA (BioLegend; MMS-101P), Ltn1/RNF160 (Ab-
cam; ab104375), RPS3 (Bethyl; A303-840A), RPL7 (Bethyl; A300-
741A), and TTLL1 (Thermo Fisher; PA5-27285).
Knockdown studies
siRNA oligos were transfected into cells using RNAiMax (Thermo 
Fisher) according to the manufacturer guidelines at a final concen-









Cell line generation and proximity labeling
293T and HCT116 cells were obtained from the American Type Cul-
ture Collection. Codon regions for the proteins of interest were re-
combined into FRT-tetO-FLAG-HA, BirA*-FLAG, or FLAG-APEX2 
destination vectors using Gateway (Thermo Fisher) cloning methods. 
293 Flp-In T-REx cell lines (Thermo Fisher catalogue number R78007) 
were transfected with Flp recombinase vector (pOG44) and FRT-
tetO-expression vectors, and stable cell lines were selected with 
hygromycin. Cells were cultured in DMEM (High Glucose; Thermo 
Fisher catalogue #11995073) supplemented with 10% fetal bovine 
serum and penicillin/streptomycin. Protein expression was induced 
by adding 1 μg/ml doxycycline to the growth media for 16–20 h 
prior to cell harvesting. For cell lines expressing BirA*-tagged pro-
teins, 50 μM biotin and 1 μg/ml doxycycline was added to the 
growth media for 16–20 h prior to cell harvesting. For cell lines ex-
pressing APEX2-tagged proteins, after 16 h dox treatment, cells 
were treated with 500 μM biotin-phenol (AdipoGen) for 1 h followed 
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by a 1-min treatment of 1.5 mM hydrogen peroxide. The reaction 
was quenched by addition of cold phosphate-buffered saline (PBS) 
with 5 mM Trolox and 10 mM sodium ascorbate to the cells.
Sucrose density gradient analysis
Cell lysis for sucrose gradient analysis was performed using digito-
nin lysis buffer (25 mM HEPES, pH 7.4, 125 mM KAc, 15 mM 
MgAc2, 100 μg/ml digitonin, supplemented with 40U/ml RNase 
inhibitor, 50 μg/ml CHX, 1 mM dithiothreitol, and protease inhibi-
tors). Protein (1.5 mg) was loaded onto a linear 5–45% sucrose gra-
dient prepared using a gradient master (Biocomp). Ultracentrifu-
gation was performed using a Beckman Coulter SW41 rotor at 
35,000 rpm for 2.5 h. Fractions (1 ml) were collected manually start-
ing from the top of the gradient. Fractions were then mixed with 
trichloroacetic acid (TCA) at a final concentration of 20%. Protein 
precipitates were washed once with 10% TCA, followed by three 
washes with 100% cold acetone. Protein precipitates were resus-
pended in 1× Laemmli sample buffer.
Sample processing for proteomics
Frozen cell pellets were lysed in mammalian cell lysis buffer (0.5% 
NP-40, 150 mM NaCl, 50 mM Tris, pH 7.8, protease inhibitors, 
10 mM N-ethylmaleimide) at 4°C at an approximate 2:1 (vol:vol) 
ratio per pellet. Lysates were sonicated and clarified by centrifuga-
tion. Total protein was quantified using a bicinchoninic acid (BCA) 
protein assay (Pierce). For either FLAG or HA immunoprecipitation, 
cell lysates were mixed with 80 μl (1:1 slurry) of αHA-conjugated or 
αFLAG-conjugated agarose beads and incubated at 4°C overnight 
with constant rotation. For APEX2 and BioID samples, lysates were 
mixed with 80 μl (1:1 slurry) of streptavidin-conjugated agarose 
beads. After overnight incubations, the resin was washed 3× in wash 
buffer (0.1% NP-40, 150 mM NaCl, 50 mM Tris, pH 7.8, protease 
inhibitors) followed by three washes in cold PBS. For HA-IPs, pro-
teins were eluted by addition of purified HA peptide (250 μg/ml). 
Proteins were precipitated from the eluate using a final concentra-
tion of 20% TCA. Protein precipitates were washed once with 10% 
TCA, followed by three washes with 100% cold acetone. Dried pre-
cipitates were digested with trypsin overnight at 37°C. (sequencing 
grade, Promega). For FLAG-IPs and streptavidin pull downs, trypsin 
was added to the washed resin and incubated overnight. Trypsin 
digested samples were desalted using the C18 stage-tip method.
Mass spectrometry
Eluted peptides were analyzed by liquid chromatography–mass 
spectrometry using a Q-Exactive (Thermo Fisher) and a nanoLC-
easy 1000 (Thermo Fisher) essentially as described (Gendron et al., 
2016). A 1-h method with a 5–45% acetonitrile gradient was used. 
Data were processed and searched using the SEQUEST algorithm 
as described (Gendron et al., 2016). For SILAC-based mapping of 
p97/VCP interacting proteins, proteins were considered as p97/
VCP interacting proteins if the average Log2 SILAC ratio (H:L) be-
tween replicate experiments was less than –1, and the protein was 
quantified in at least two replicate experiments. For label-free pro-
teomics, the D-score for all interacting proteins for both GFP and 
Ltn1 was calculated using CompPASS scoring (Sowa et al., 2009). 
The D-score was normalized to the average D-score for all interact-
ing proteins (both GFP and Ltn1) across all six conditions. Proteins 
were assigned as high confidence Ltn1 interacting proteins if the 
difference in the normalized D-score between GFP and Ltn1 (i.e., 
FH-Ltn1 D-score – FH-GFP D-score) was greater than 2. Mass spec-
trometry RAW files have been deposited at MassIVE and can be 
accessed with the accession number MSV000082006.
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